Hamburg - Delayed Quote EUR

Clinuvel Pharmaceuticals Ltd (UR9.HM)

Compare
8.01 +0.06 (+0.69%)
As of 5:25 PM GMT+1. Market Open.
Loading Chart for UR9.HM
DELL
  • Previous Close 7.95
  • Open 8.01
  • Bid 8.01 x --
  • Ask 8.07 x --
  • Day's Range 8.01 - 8.01
  • 52 Week Range 7.89 - 10.73
  • Volume 0
  • Avg. Volume 22
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Feb 20, 2025 - Feb 24, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: UR9.HM

View More

Performance Overview: UR9.HM

Trailing total returns as of 11/28/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

UR9.HM
17.38%
S&P/ASX 200 [XJO]
11.24%

1-Year Return

UR9.HM
22.05%
S&P/ASX 200 [XJO]
20.37%

3-Year Return

UR9.HM
56.39%
S&P/ASX 200 [XJO]
16.00%

5-Year Return

UR9.HM
52.14%
S&P/ASX 200 [XJO]
23.02%

Compare To: UR9.HM

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: UR9.HM

View More

Valuation Measures

Annual
As of 11/27/2024
  • Market Cap

    402.89M

  • Enterprise Value

    289.95M

  • Trailing P/E

    18.45

  • Forward P/E

    18.18

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.46

  • Price/Book (mrq)

    3.18

  • Enterprise Value/Revenue

    5.33

  • Enterprise Value/EBITDA

    8.35

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: UR9.HM

View More

Company Insights: UR9.HM

Research Reports: UR9.HM

View More

People Also Watch